COPD total solution symposium

The prevalence of COPD in 2015 was 13.4% (male, 21.6%; female, 5.8%) in Korea. The prevalence of COPD did not change much, which ranged from 13.1% to 14.6% during the period from 2010 to 2015 (data from Korea National Health and Nutrition Examination Survey). Many COPD patients still had not been diagnosed by physicians and consequently had not been treated appropriately.

Course information


Dr Eui-Sik Suh


South Korean


Gachon University Gil Medical Center, 603, Namdong-Gu, Incheon, Korea


Registration Closed

Registration Fee


Seats Available


Download Course Flyer


In this Symposium, Dr. Suh will review recent developments in the treatment of COPD with drug treatment (including nebulization) and rehabilitation to improve the patients quality of life, increase  their capacity for exercise and ultimately, keep well and out of hospital. In particular he will consider the causes of type II respiratory failure and the evidence base for the use of home noninvasive mechanical ventilation, and HFOT in COPD. He will also review current indications for ambulatory oxygen.


05:00 pm - 05:30 pm Registration & Coffee
05:30 pm - 05:45 pm Welcome Address
05:45 pm - 07:00 pm Use of inhaled therapy in COPD, Monitoring disease progression in COPD patients, Oxygen therapy for COPD patients, Pulmonary rehabilitation in COPD, Comparison of HFNC and NIV in COPD
07:00 pm - 07:15 pm Guide of mask type and optimal size selection
07:15 pm - 07:30 pm Ventilator modes for NIV in COPD patients
07:30 pm Closing remark

About speaker

Dr Eui-Sik Suh

Dr Eui-Sik Suh is a Consultant in Respiratory and Ventilation Medicine at the Lane Fox Respiratory Service, St Thomas' Hospital, London. He is also an Honorary Senior Lecturer in medical education in the Faculty of Life Sciences and Medicine at King's College London. He completed an undergraduate degree in chemistry at the University of Oxford prior to embarking on medical studies at University College London. He completed his specialist training in Respiratory Medicine in London. He was awarded a PhD in Clinical Respiratory Physiology by King's College London for research into respiratory muscle physiology during exacerbations of COPD. His research interests remain in COPD exacerbation physiology and chronic respiratory failure.